Clinical Trial Update: Safety and Efficacy of Silodosin in the Treatment of Premature Ejaculation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating the safety and efficacy of silodosin for premature ejaculation; current status of the study is not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• Silodosin (Silodosin)

Snippet

Sponsor: Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation | Conditions: Premature Ejaculation | Phase 2 | Status: UNKNOWN